# Becton, Dickinson and Company (BDX): MoatMap facts

As of 12 Nov 2026. Research data, not investment advice.

As of 12 Nov 2026, the MoatMap Score for Becton, Dickinson and Company (BDX) is 87/100, ranked against 25,000+ stocks in 38 markets (Quality 52, Value 47, Momentum 88, each scored against its sector).

- MoatMap Score: 87/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 52, Value 47, Momentum 88: each a 0-100 percentile within Healthcare.
- Position: #3,502 overall, #388 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Instruments & Supplies.
- Last close: 214.52 USD on 11 Nov 2026.
- Insider filings, last 180 days: directors sold USD 2.7M.

Source: https://moatmap.ai/stock/BDX
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker